This session addresses rheumatic and systemic autoimmune diseases affecting joints, connective tissues, blood vessels, and multiple organ systems. Topics may include inflammatory arthritis, lupus, vasculitis, connective tissue disorders, systemic sclerosis, myositis, disease overlap, clinical complications, and advances in diagnosis, monitoring, and treatment.
Abstracts are invited on clinical care, imaging, biomarkers, immunopathogenesis, rehabilitation, biologic therapies, patient-reported outcomes, and multidisciplinary disease management. The session welcomes rheumatologists, clinical immunologists, internists, rehabilitation professionals, researchers, nurses, pharmacists, and healthcare teams working with systemic autoimmune conditions.
Title : Antibody proteases as translational biomarkers, targets, and biocatalysts of the next generation step as applicable for design driven precision medical practice
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through biodesign inspired and immunology related translational applications to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Targeting tumor-associated antigens through variable epitope libraries: Antitumor activity in breast cancer and acute myeloid leukemia
Braulio Alejandro Martinez Zarco, UNAM, Mexico
Title : Ultra-low-dose methotrexate combined with low-dose prednisolone in two distinct chronic disorders: A hypothesis-generating clinical comparison
Naylya Djumaeva, Research Institute of Virology, Uzbekistan
Title : Treatment outcomes of adult Filipino patients with drug susceptible pulmonary and extrapulmonary tuberculosis after anti-Koch’s rechallenge regimen
Jizelle Kay Cofulan Fang Asan, Baguio General Hospital and Medical Center, Philippines
Title : Clinical, immunological, and cytokine profiles of primary Sjögren’s syndrome in a Western Algerian population
Ouikhlef Narjesse, EHU Oran & Faculty of Medicine of Oran, Algeria